Morgan Stanley »

Talis Biomedical Corporation shares owned by Morgan Stanley

Quarter-by-quarter ownership of Talis Biomedical Corporation (TLIS) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Talis Biomedical Corporation

Tip: Access up to 7 years of quarterly data

All positions including Talis Biomedical Corporation held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Talis Biomedical Corporation by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.6k 635 8.75
2023-09-30 $13k 2.3k 5.77

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Talis Biomedical Corporation

Baker Bros. Advisors
Greenlight Capital
DME Capital Management
BML Capital Management
Vanguard Group
Susquehanna International
Springbok Capital Management
Geode Capital Management
BlackRock
Tower Research Capital
Morgan Stanley
ADAR1 Capital Management
Advisor Group Holdings
UBS Group
Larson Financial Group

View all funds holding Talis Biomedical Corporation